Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.

Cancer research and treatment - 1 Jul 2016

Myung Jae Kyung, Kwak Byung Kuk, Lim Jung Ah, Lee Myung-Chul, Kim Min Joo

Abstract excerpt

PURPOSE: A telomerase reverse transcriptase (TERT) promoter mutation was identified in thyroid cancer. This TERT promoter mutation is thought to be a prognostic molecular marker, because its association with tumor aggressiveness, persistence/recurrence, and disease-specific mortality in papillary thyroid carcinoma (PTC) has been reported. In this study, we attempted to determine whether the impact of the TERT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Propensity Score

Share to Proto-Oncogene Proteins B-raf

Share to Telomerase

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Thyroidectomy

Source

Open in PubMed Open full text

Identifiers

PMID: 26727717
DOI: 10.4143/crt.2015.362
PMCID: PMC4946362

Genes

TERT
BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.PMID 26727717Read ↗

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.Semantic proximity Read ↗

Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.Semantic proximity Read ↗

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid CarcinomasSemantic proximity Read ↗

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.Semantic proximity Read ↗

Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.Semantic proximity Read ↗

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.Semantic proximity Read ↗

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.Semantic proximity Read ↗

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients.Semantic proximity Read ↗

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis.Semantic proximity Read ↗

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid CancerSemantic proximity Read ↗

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in KoreaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.